Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) EBT Margin (2017 - 2020)

Historic EBT Margin for Cogent Biosciences (COGT) over the last 4 years, with Q3 2020 value amounting to 18325.64%.

  • Cogent Biosciences' EBT Margin fell 171486800.0% to 18325.64% in Q3 2020 from the same period last year, while for Dec 2020 it was 1042.5%, marking a year-over-year decrease of 9006600.0%. This contributed to the annual value of 10507.38% for FY2025, which is N/A changed from last year.
  • As of Q3 2020, Cogent Biosciences' EBT Margin stood at 18325.64%, which was down 171486800.0% from 1401.52% recorded in Q2 2020.
  • In the past 5 years, Cogent Biosciences' EBT Margin registered a high of 15.05% during Q4 2019, and its lowest value of 18325.64% during Q3 2020.
  • In the last 4 years, Cogent Biosciences' EBT Margin had a median value of 327.26% in 2017 and averaged 1634.34%.
  • Within the past 5 years, the most significant YoY rise in Cogent Biosciences' EBT Margin was 2962600bps (2020), while the steepest drop was -171486800bps (2020).
  • Quarter analysis of 4 years shows Cogent Biosciences' EBT Margin stood at 319.41% in 2017, then rose by 29bps to 225.91% in 2018, then soared by 107bps to 15.05% in 2019, then plummeted by -121857bps to 18325.64% in 2020.
  • Its EBT Margin was 18325.64% in Q3 2020, compared to 1401.52% in Q2 2020 and 86.67% in Q1 2020.